Alison F. Munro

3.0k total citations
54 papers, 2.2k citations indexed

About

Alison F. Munro is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Alison F. Munro has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Alison F. Munro's work include HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (8 papers) and Cancer-related Molecular Pathways (5 papers). Alison F. Munro is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (8 papers) and Cancer-related Molecular Pathways (5 papers). Alison F. Munro collaborates with scholars based in United Kingdom, United States and Canada. Alison F. Munro's co-authors include John M.S. Bartlett, Joanne Edwards, C.J. Packard, A R Lorimer, A M Gotto, J. Shepherd, David Cameron, Jeremy Thomas, Neil O. Carragher and R Mukherjee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Alison F. Munro

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison F. Munro United Kingdom	26	855	850	557	285	258	54	2.2k
Rossano Lattanzio Italy	29	959 1.1×	1.3k 1.5×	436 0.8×	290 1.0×	229 0.9×	83	2.7k
Uma Raju United States	32	1.0k 1.2×	1.2k 1.4×	484 0.9×	597 2.1×	171 0.7×	102	2.7k
José Palacios Spain	26	870 1.0×	1.5k 1.8×	441 0.8×	288 1.0×	214 0.8×	58	2.9k
Khalil Helou Sweden	27	508 0.6×	1.2k 1.5×	514 0.9×	296 1.0×	172 0.7×	114	2.2k
Shingo Tsuji Japan	26	519 0.6×	1.1k 1.2×	407 0.7×	369 1.3×	509 2.0×	78	2.7k
Michael Höpfner Germany	29	623 0.7×	1.2k 1.4×	384 0.7×	419 1.5×	257 1.0×	64	2.5k
Pierre‐Marie Martin France	34	796 0.9×	1.3k 1.5×	747 1.3×	562 2.0×	205 0.8×	99	3.4k
Ken‐Ichiro Yoshida Japan	28	593 0.7×	924 1.1×	229 0.4×	769 2.7×	302 1.2×	118	2.4k
Adriano Angelucci Italy	36	962 1.1×	1.7k 2.0×	674 1.2×	609 2.1×	173 0.7×	106	3.3k
Iván P. Uray United States	20	434 0.5×	1.3k 1.6×	267 0.5×	179 0.6×	204 0.8×	40	2.3k

Countries citing papers authored by Alison F. Munro

Since Specialization

Citations

This map shows the geographic impact of Alison F. Munro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison F. Munro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison F. Munro more than expected).

Fields of papers citing papers by Alison F. Munro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison F. Munro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison F. Munro. The network helps show where Alison F. Munro may publish in the future.

Co-authorship network of co-authors of Alison F. Munro

This figure shows the co-authorship network connecting the top 25 collaborators of Alison F. Munro. A scholar is included among the top collaborators of Alison F. Munro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison F. Munro. Alison F. Munro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rifai, Olivia M., Owen Dando, Alison F. Munro, et al.. (2023). Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts. Brain. 146(12). 5124–5138. 7 indexed citations

Elliott, Richard, et al.. (2020). High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. SLAS DISCOVERY. 25(7). 770–782. 16 indexed citations

Hearn, Jessica M., G. M. Hughes, Isolda Romero‐Canelón, et al.. (2017). Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action. Metallomics. 10(1). 93–107. 41 indexed citations

Spears, Melanie, Fouad Yousif, Paul C. Boutros, et al.. (2015). A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials. Oncotarget. 6(31). 31693–31701. 7 indexed citations

Munro, Alison F., Eva Balslev, Christopher Twelves, et al.. (2013). Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?. Breast Cancer Research. 15(2). R31–R31. 3 indexed citations

Ali, Alaa M., Elena Provenzano, John M.S. Bartlett, et al.. (2013). Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer. 133(6). 1470–1478. 13 indexed citations

Spears, Melanie, Karen J. Taylor, Alison F. Munro, et al.. (2011). In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer. Breast Cancer Research and Treatment. 132(2). 463–470. 59 indexed citations

Pritchard, Kathleen I., Alison F. Munro, Frances P. O’Malley, et al.. (2011). Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial. Breast Cancer Research and Treatment. 131(2). 541–551. 16 indexed citations

Spears, Melanie, Steffi Oesterreich, Ilenia Migliaccio, et al.. (2011). The p160 ER co-regulators predict outcome in ER negative breast cancer. Breast Cancer Research and Treatment. 131(2). 463–472. 14 indexed citations

10.

Nes, Johanna G. H. van, Esther M. de Kruijf, Hein Putter, et al.. (2011). Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients. Breast Cancer Research and Treatment. 133(1). 49–59. 74 indexed citations

11.

Bartlett, John M.S., Jeremy Thomas, Douglas T. Ross, et al.. (2010). Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. Breast Cancer Research. 12(4). R47–R47. 85 indexed citations

12.

Faratian, Dana, Alison F. Munro, Christopher Twelves, & John M.S. Bartlett. (2009). Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 54(2). 254–257. 55 indexed citations

13.

Munro, Alison F., Christine Desmedt, Janet Dunn, et al.. (2009). Duplication of Chromosome 17 CEP Predicts for Anthracycline Benefit: A Meta-Analysis of 4 Trials.. Cancer Research. 69(24_Supplement). 4030–4030. 2 indexed citations

14.

Bartlett, John M.S., Alison F. Munro, David Cameron, et al.. (2008). Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial. Journal of Clinical Oncology. 26(31). 5027–5035. 67 indexed citations

15.

Aubele, Michaela, Gert Auer, Axel Walch, et al.. (2007). PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. British Journal of Cancer. 96(5). 801–807. 72 indexed citations

16.

Kirkegaard, Thomas, Joanne Edwards, Sian Tovey, et al.. (2006). Observer variation in immunohistochemical analysis of protein expression, time for a change?. Histopathology. 48(7). 787–794. 199 indexed citations

17.

Bartlett, John M.S., et al.. (2005). Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer. The Journal of Pathology. 205(4). 522–529. 50 indexed citations

18.

Edwards, Joanne, et al.. (2003). HER2 and COX2 expression in human prostate cancer. European Journal of Cancer. 40(1). 50–55. 78 indexed citations

19.

Guttmann, L, Alison F. Munro, R. Robinson, & John J. Walsh. (1963). Effect of tilting on the cardiovascular responses and plasma catecholamine levels in spinal man. Spinal Cord. 1(1). 4–18. 53 indexed citations

20.

Munro, Alison F.. (1953). THE EFFECT OF ADRENALINE AND NORADRENALINE ON THE ACTIVITY OF ISOLATED PREPARATIONS OF THE GUT FROM THE FOETAL GUINEA‐PIG. British Journal of Pharmacology and Chemotherapy. 8(1). 38–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact